Pfizer/BioNTech: BNT162b2 (B.1.1.7)

Vaccine Type: RNA

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 2 trials.

About Trial Phases

Phase 1: 0 Trials

There are no trials for this phase.

Phase 2: 1 Trial

  • NCT05004181
    Germany, South Africa, Turkey, United States of America

Phase 3: 0 Trials

There are no trials for this phase.

Approvals

This vaccine is not yet approved.

Registered Trials